An anti-apoptotic antioxidant
Related Products
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

(R)-Pramipexole (hydrochloride)

Item No. 18234

Technical Information
Formal Name
4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazolediamine, dihydrochloride
CAS Number
104632-27-1
Synonyms
  • Dexpramipexole
  • KNS 760704
  • (+)-Pramipexole
  • SND 919CL2X
Molecular Formula
C10H17N3S • 2HCl
Formula Weight
Purity
≥95%
A crystalline solid
DMSO: 5 mg/mlPBS (pH 7.2): 10 mg/ml
λmax
219, 264 nm
SMILES
CCCN[C@@H]1CCC(N=C(N)S2)=C2C1.Cl.Cl
InChi Code
InChI=1S/C10H17N3S.2ClH/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8;;/h7,12H,2-6H2,1H3,(H2,11,13);2*1H/t7-;;/m1../s1
InChi Key
QMNWXHSYPXQFSK-XCUBXKJBSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    (R)-Pramipexole is an enantiomer of pramipexole that is ~100-fold less active than the (S) form as a dopamine receptor agonist.1,2 For this reason, it can be used as a negative control for the (S) form in the study of dopamine receptors. Both isoforms are antioxidants that target mitochondria to prevent apoptosis.1,3,4,5 This cytoprotective effect of (R)-pramipexole, without dopaminergic side effects, suggests utility in amyotrophic lateral sclerosis.1,6

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Danzeisen, R., Schwalenstoecker, B., Gillardon, F., et alTargeted antioxidative and neuroprotective properties of the dopamine agonist pramipexole and its nondopaminergic enantiomer SND919CL2x [(+)2-amino-4,5,6,7-tetrahydro-6-Lpropylamino-benzathiazole dihydrochloride]. JPET 316(1), 189-199 (2006).

    2. Chang, W.I., Weber, M., Breier, M.R., et alStereochemical and neuroanatomical selectivity of pramipexole effects on sensorimotor gating in rats. Brain Res. 1437, 69-76 (2012).

    3. Ferrari-Toninelli, G., Maccarinelli, G., Uberti, D., et alMitochondria-targeted antioxidant effects of S(−) and R(+) pramipexole. BMC Pharmacol. 10(2), 1-6 (2010).

    4. Abramova, N.A., Cassarino, D.S., Khan, S.M., et alInhibition by R(+) or S(−) pramipexole of caspase activation and cell death induced by methylpyridinium ion orβamyloid peptide in SH-SY5Y neuroblastoma. J. Neurosci. Res. 67(4), 494-500 (2002).

    5. Gu, M., Iravani, M.M., Cooper, J.M., et alPramipexole protects against apoptotic cell death by non-dopaminergic mechanisms. J. Neurochem. 91(5), 1075-1081 (2004).

    6. Cheah, B.C., and Kiernan, M.C. Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis. IDrugs. 13(12), 911-920 (2010).